SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001213900-20-008164
Filing Date
2020-03-31
Accepted
2020-03-31 11:31:20
Documents
6

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO FORM F-1 ea120248-f1a4_therapixbio.htm F-1/A 1449356
2 FORM OF SECURITIES PURCHASE AGREEMENT ea120248ex4-7_therapix.htm EX-4.7 246843
3 FORM OF PRE-FUNDED WARRANT ea120248ex4-8_therapix.htm EX-4.8 95330
4 FORM OF SERIES B WARRANT ea120248ex4-9_therapix.htm EX-4.9 123098
5 CONSENT OF KOST, FORER, GABBAY & KASIERER, A MEMBER OF EY GLOBAL. ea120248ex23-1_therapix.htm EX-23.1 2765
6 GRAPHIC image_001.jpg GRAPHIC 29351
  Complete submission text file 0001213900-20-008164.txt   1958991
Mailing Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047
Business Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047 972-3-6167055
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-236175 | Film No.: 20760441
SIC: 2834 Pharmaceutical Preparations